Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Division of Cancer Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Cancer Med. 2022 Jan;11(2):507-519. doi: 10.1002/cam4.4457. Epub 2021 Nov 29.
An increasing number of cancer survivors have developed multiple primaries. This study aims to describe the incidence and risk patterns of metachronous second primary cancers (SPCs) in Osaka, Japan.
Data were obtained from the Osaka Cancer Registry, a population-based database of all cancers diagnosed in Osaka. The study subjects were individuals who were first diagnosed with invasive cancers in 16 major cancer sites during 2000-2014, aged 15-79 years, survived at least 3 months, and were followed up for 10 years. We measured incidence rates, cumulative risks, and standardized incidence ratios (SIRs: with the Osaka general population as the referent) of developing SPCs during 3 months to 10 years after the first diagnosis.
During 2000-2015, among 418,791 cancer survivors, 24,368 (5.8%) developed SPCs within 10 years of first diagnosis. Males had higher incidence rates than females except among young-onset survivors (aged 15-39 years). 10-year cumulative risks among survivors aged 70-79 years (the most dominant age group) were 24.0% (male) and 11.8% (female). 10-year SIRs were 1.38 (95% CI, 1.36-1.40; male) and 1.44 (95% CI, 1.41-1.48; female) with higher estimates among younger survivors in both sexes. Strong bidirectional associations were observed between oral/pharyngeal, esophageal, and laryngeal cancers. Survivors of any smoking-related cancers had elevated SIRs of developing smoking-related SPCs. Similar results were observed for alcohol-related cancers.
Cancer survivors are at excess risk of developing SPCs compared to the general population. Continued surveillance is warranted to inform survivorship care through risk-based long-term care planning and lifestyle-changing efforts to prevent new cancers.
越来越多的癌症幸存者出现了多种原发性疾病。本研究旨在描述日本大阪地区同时性第二原发癌(metachronous second primary cancer,SPC)的发病情况和风险模式。
数据来自大阪癌症登记处,这是一个基于人群的数据库,包含了大阪地区所有癌症的诊断信息。研究对象为 2000 年至 2014 年期间在 16 个主要癌症部位首次被诊断为浸润性癌症、年龄在 15-79 岁之间、至少存活 3 个月且随访 10 年的个体。我们测量了在首次诊断后 3 个月至 10 年内发展 SPC 的发病率、累积风险和标准化发病比(standardized incidence ratio,SIR:以大阪一般人群为参照)。
在 2000 年至 2015 年期间,在 418791 名癌症幸存者中,有 24368 名(5.8%)在首次诊断后 10 年内患上了 SPC。男性的发病率高于女性,但在年轻发病的幸存者(年龄在 15-39 岁)中除外。在 70-79 岁年龄组(占主导地位的年龄组)的幸存者中,10 年累积风险为 24.0%(男性)和 11.8%(女性)。10 年 SIR 分别为 1.38(95%CI,1.36-1.40;男性)和 1.44(95%CI,1.41-1.48;女性),在两性中年轻幸存者的估计值更高。口腔/咽、食管和喉癌之间存在强烈的双向关联。任何与吸烟相关的癌症幸存者发生与吸烟相关的 SPC 的 SIR 均升高。与酒精相关的癌症也观察到类似的结果。
与一般人群相比,癌症幸存者发生 SPC 的风险更高。需要进行持续监测,以便通过基于风险的长期护理计划和改变生活方式的努力来预防新发癌症,为生存者护理提供信息。